Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1213513/full |
| _version_ | 1827946840114331648 |
|---|---|
| author | Hon-Yi Lin Hon-Yi Lin Hon-Yi Lin Hon-Yi Lin Michael W. Y. Chan Vivian W. Y. Lui Peter J. K. Kuppen Shih-Kai Hung Shih-Kai Hung Shih-Kai Hung |
| author_facet | Hon-Yi Lin Hon-Yi Lin Hon-Yi Lin Hon-Yi Lin Michael W. Y. Chan Vivian W. Y. Lui Peter J. K. Kuppen Shih-Kai Hung Shih-Kai Hung Shih-Kai Hung |
| author_sort | Hon-Yi Lin |
| collection | DOAJ |
| first_indexed | 2024-03-13T11:06:42Z |
| format | Article |
| id | doaj.art-9e4dd9355e9340068281c29f8c7ef92e |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-13T11:06:42Z |
| publishDate | 2023-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-9e4dd9355e9340068281c29f8c7ef92e2023-05-16T05:44:49ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.12135131213513Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical applicationHon-Yi Lin0Hon-Yi Lin1Hon-Yi Lin2Hon-Yi Lin3Michael W. Y. Chan4Vivian W. Y. Lui5Peter J. K. Kuppen6Shih-Kai Hung7Shih-Kai Hung8Shih-Kai Hung9Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, TaiwanCancer Centre, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, TaiwanSchool of Medicine, Tzu Chi University, Hualien, TaiwanDepartment of Biomedical Sciences, National Chung Cheng University, Chia-Yi, TaiwanDepartment of Biomedical Sciences, National Chung Cheng University, Chia-Yi, TaiwanGeorgia Cancer Center and Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United StatesDepartment of Surgical Oncology, Leiden University Medical Centre, ZA, Leiden, NetherlandsDepartment of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, TaiwanCancer Centre, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, TaiwanSchool of Medicine, Tzu Chi University, Hualien, Taiwanhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1213513/fullradiotherapy (RT)immunotherapyepigenetic modificationcancerimmune-oncology (IO) |
| spellingShingle | Hon-Yi Lin Hon-Yi Lin Hon-Yi Lin Hon-Yi Lin Michael W. Y. Chan Vivian W. Y. Lui Peter J. K. Kuppen Shih-Kai Hung Shih-Kai Hung Shih-Kai Hung Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application Frontiers in Oncology radiotherapy (RT) immunotherapy epigenetic modification cancer immune-oncology (IO) |
| title | Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application |
| title_full | Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application |
| title_fullStr | Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application |
| title_full_unstemmed | Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application |
| title_short | Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application |
| title_sort | editorial the role of epigenetic modification in radiotherapy and immuno oncology in cancer from bench to clinical application |
| topic | radiotherapy (RT) immunotherapy epigenetic modification cancer immune-oncology (IO) |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1213513/full |
| work_keys_str_mv | AT honyilin editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT honyilin editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT honyilin editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT honyilin editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT michaelwychan editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT vivianwylui editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT peterjkkuppen editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT shihkaihung editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT shihkaihung editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication AT shihkaihung editorialtheroleofepigeneticmodificationinradiotherapyandimmunooncologyincancerfrombenchtoclinicalapplication |